SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-23-058266
Filing Date
2023-03-02
Accepted
2023-03-02 16:45:24
Documents
5
Effectiveness Date
2023-03-02

Document Format Files

Seq Description Document Type Size
1 POSASR d449320dposasr.htm POSASR 258237
2 EX-23.2 d449320dex232.htm EX-23.2 1822
3 EX-24.2 d449320dex242.htm EX-24.2 3121
4 EX-FILING FEES d449320dexfilingfees.htm EX-FILING FEES 32221
5 GRAPHIC g449320g95b59.jpg GRAPHIC 29529
  Complete submission text file 0001193125-23-058266.txt   334016
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-263225 | Film No.: 23699802
SIC: 2834 Pharmaceutical Preparations